Your browser doesn't support javascript.
loading
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study.
de Joode, Karlijn; Dumoulin, Daphne W; Tol, Jolien; Westgeest, Hans M; Beerepoot, Laurens V; van den Berkmortel, Franchette W P J; Mutsaers, Pim G N J; van Diemen, Nico G J; Visser, Otto J; Oomen-de Hoop, Esther; Bloemendal, Haiko J; van Laarhoven, Hanneke W M; Hendriks, Lizza E L; Haanen, John B A G; de Vries, Elisabeth G E; Dingemans, Anne-Marie C; van der Veldt, Astrid A M.
Affiliation
  • de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Dumoulin DW; Department of Pulmonary Diseases, Erasmus MC, Rotterdam, the Netherlands.
  • Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.
  • Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.
  • van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
  • Mutsaers PGNJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Diemen NGJ; Department of Internal Medicine, Bernhoven, Uden, the Netherlands.
  • Visser OJ; Department of Hematology, Isala Hospital, Zwolle, the Netherlands.
  • Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Hendriks LEL; Department of Pulmonary Diseases GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Dingemans AC; Department of Pulmonary Diseases, Erasmus MC, Rotterdam, the Netherlands.
  • van der Veldt AAM; Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.
Eur J Cancer ; 141: 171-184, 2020 12.
Article in En | MEDLINE | ID: mdl-33161241
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2020 Document type: Article Affiliation country: Country of publication: